Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
604.16604.16610.19604.12
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
1,197.811,200.581,213.071,192.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
634.44633.13639.87633.01
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
840.90839.53841.73831.10
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
215.13215.13215.85213.24
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
3,228.713,225.623,235.433,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
935.87938.37942.00935.65
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
1,457.121,452.741,466.881,449.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
2,399.842,389.712,394.612,371.22
007570:KRX
Ilyang Pharmaceutical Co Ltd
₩11,380.00
-2.07%
(-240.00) 1D
Apr 28, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 007570...
Open
₩11,590
High
₩11,750
Low
₩11,370
Mkt. cap
221.98B
Avg. vol.
113.43K
Volume
93.38K
Dividend
1.36%
Quarterly dividend
₩39
Ex dividend date
Dec 27, 2023
P/E ratio
30.36
52-wk high
₩16,240
52-wk low
₩10,780
EPS
₩375
Shares outstanding
19.09M
No. of employees
670
News stories
From sources across the web
About Ilyang Pharmaceutical Co Ltd
CEOKim Dong-yeon
Employees670
FoundedJul 1, 1946
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
61.98B
62.70B
68.83B
78.91B
Cost of goods sold
33.47B
35.93B
41.32B
45.42B
Cost of revenue
33.47B
35.93B
41.32B
45.42B
Research and development expenses
6.14B
5.94B
7.01B
7.00B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.36B
19.05B
19.76B
24.92B
Operating expense
25.13B
25.60B
27.66B
32.93B
Total operating expenses
58.60B
61.53B
68.98B
78.35B
Operating income
3.38B
1.17B
-157.75M
565.93M
Other non operating income
1.51B
-969.70M
11.87B
-681.30M
EBT including unusual items
3.37B
192.59M
11.42B
-1.72B
EBT excluding unusual items
3.32B
179.37M
11.35B
-1.72B
Income tax expense
-404.58M
-420.76M
3.04B
3.92B
Effective tax rate
-12.00%
-218.48%
26.58%
-227.04%
Other operating expenses
410.51M
400.58M
639.84M
573.32M
Net income
3.54B
576.52M
8.44B
-5.65B
Net profit margin
5.71%
0.92%
12.26%
-7.16%
Earnings per share
-
-
-
-
Interest and investment income
232.25M
85.56M
-
184.97M
Interest expense
-1.55B
-744.99M
-
-738.07M
Net interest expenses
-1.32B
-659.43M
-
-553.10M
Depreciation and amortization charges
204.12M
208.06M
212.18M
210.49M
EBITDA
5.47B
3.26B
1.93B
2.65B
Gain or loss from assets sale
-151.75K
-17.86M
-71.72M
6.86K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more